The State of Wisconsin Investment Board has given preliminary approval to allocating up to $50 million to two new venture capital funds proposed by state firms Mason Wells and Venture Investors.
The Mason Wells Biomedical Fund II and Venture Investors Early Stage Fund IV are planned to focus on seed and early stage financing of life science opportunities coming out of Wisconsin universities and medical research facilities, said Monica Jaehnig, Wisconsin private equity portfolio manager. But the investments will not be limited to state firms.